Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

Optimizing the Approval Pathway for Biosimilars to Treat Psoriasis and Psoriatic Arthritis

Journal of Psoriasis and Psoriatic Arthritis®

Journal indexing and metrics

Journal Homepage Submission guidelines

Restricted access

Editorial

First published online March, 2012

Optimizing the Approval Pathway for Biosimilars to Treat Psoriasis and Psoriatic Arthritis

and

Volume 18a, Issue 1

https://doi.org/10.1177/247553031218a00107

Abstract

Keywords

biologics biosimilars psoriasis

Get full access to this article

View all access options for this article.

Browse journal

Current issue OnlineFirst All issues

Similar articles

Retricted access

Efficacy of Biosimilars in Psoriasis

Retricted access

Biosimilars in Dermatology: Analytical,Regulatory,and Clinical Considerations: A Treatise From the Medical Board of the National Psoriasis Foundation

Free access

The First Interchangeable Biosimilar Insulin: Insulin Glargine-yfgn

Retricted access

Treatment of Moderate to Severe Psoriasis With High-Dose (450-mg) Secukinumab: Case Reports of Off-Label Use